Cholinergic modulation of the Ca2+ response to bradykinin in neuroblastoma cells

American Journal of Physiology - Cell Physiology

Volumn 273, Issue 2 42-2, 1997, Pages

  Coggan, Jay S ^a   Thompson, Stuart H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Agonist interaction; Calcium; Carbachol; G protein; Heterologous desensitization; Signal transduction

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; CALCIUM ION; CARBACHOL; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; BORDETELLA VIRULENCE FACTOR; CALCIUM; MUSCARINIC AGENT;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; METABOLISM; NEUROBLASTOMA; PATHOLOGY;

ANIMALIA;

ANIMALS; BRADYKININ; CALCIUM; CARBACHOL; CHOLINERGIC AGONISTS; MICE; MUSCARINIC AGONISTS; NEUROBLASTOMA; PERTUSSIS TOXIN; RECEPTORS, CHOLINERGIC; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0031204517     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1997.273.2.c612     Document Type: Article

References (24)

1. Amano, T., E. Richelson, and M. Nirenberg. Neurotransmitter synthesis by neuroblastoma clones. Proc. Natl. Acad. Sci. USA 69: 258-263, 1972.
2. Boyd, R. S., L. E. Donnelly, and J. MacDermot. Loss of responses to bradykinin, ATP or carbachol follows depletion of a shared pool of calcium ions. Eur. J. Physiol. 267: 161-166, 1994.
3. Brabet, P., C. Pantaloni, M. Rodriguez, J. Martinez, J. Bockaert, and V. Homburger. Neuroblastoma differentiation involves the expression of two isoforms of the a-subunit of Go. J. Neurochem. 54: 1310-1320, 1990.
4. 2+ increase by bradykinin or ATP in NG108-15 cells. J. Biol. Chem. 270: 16630-16637, 1995.
5. Coggan, J. S., and S. H. Thompson. Intracellular calcium signals in response to bradykinin in individual neuroblastoma cells. Am. J. Physiol. 269 (Cell Physiol. 38): C841-C848, 1995.
6. El-Fakahany, E., and E. Richelson. Effect of some calcium antagonists on muscarinic receptor-mediated cyclic GMP formation. J. Neurochem. 40: 705-710, 1983.
7. Honda, Z., T. Takano, N. Hirose, T. Suzuki, A. Muto, S. Kume, K. Mikoshiba, K. Itoh, and T. Shimizu. Gq pathway desensitizes chemotactic receptor-induced calcium signaling via inositol trisphosphate receptor down-regulation. J. Biol. Chem. 270: 4840-4844, 1995.
8. Hu, J., and E. El-Fakahany. Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells. J. Neurochem. 61: 578-585, 1993.
9. Luo, H., R. P. Lindeman, and H. S. Chase, Jr. Participation of protein kinase C in desensitization to bradykinin and to carbachol in MDCK cells. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F499-F506, 1992.
10. Malhorta, R. K., T. D. Wakade, and A. R. Wakade. Cross-communication between acetylcholine and VIP in controlling catecholamine secretion by affecting cAMP, inositol triphosphate, protein kinase C, and calcium in rat adrenal medulla. J. Neurosci. 9: 4150-4157, 1989.
11. 2+ current in neuroblastoma cells. J. Gen. Physiol. 106: 975-994, 1995.
12. 2+ influx. J. Neurosci. 16: 1702-1709, 1996.
13. Matsuzawa, H., and M. Nirenberg. Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells. Proc. Natl. Acad. Sci. USA 72: 3472-3476, 1975.
14. McGehee, D. S., M. F. Goy, and G. S. Oxford. Involvement of the nitric oxide-cyclic GMP pathway in the desensitization of bradykinin responses of cultured rat sensory neurons. Neuron 9: 315-324, 1992.
15. McKinney, M., D. J. Anderson, L. Vella-Rountree, T. Connoly, and J. H. Miller. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors. J. Pharmacol. Exp. Ther. 257: 1121-1129. 1991.
16. 2+ system through cross-talk between opioid receptors and P2-purinergic or bradykinin receptors in NG 108-15 cells. Biochem. J. 290: 241-247, 1993.
17. Rouot, B., N. Charpentier, C. Chabbert, J. Carrette, R. Zumbihl, J. Bockaert, and V. Homburger. Specific antibodies against Gq isoforms reveal the early expression of the Go2a subunit and appearance of Go1a during neuronal differentiation. Mol. Pharmacol. 41: 273-280, 1992.
18. Schulman, H. Protein phosphorylation in neuronal plasticity and gene expression. Curr. Opin. Neurobiol. 5: 375-381, 1995.
19. Snider, M. R., and E. Richelson. Bradykinin receptor-mediated cyclic GMP formation in a nerve cell population (murine neuroblastoma clone N1E-115). J. Neurochem. 43: 1749-1754, 1984.
20. 2+ elevation by muscarinic stimulation without attenuation of inositol 1,4,5-trisphosphate production in human neuroblastoma SK-N-BE(2)C cells. J. Neurochem. 65: 2124-2130, 1995
21. 2+ requirement for cGMP production during muscarinic activation of N1E-115 neuroblastoma cells. Am. J. Physiol. 269 (Cell Physiol. 38): C979-C985, 1995.
22. Wang, S. S.-H., and S. H. Thompson. Measurement of changes in functional muscarinic acetylcholine receptor density in single neuroblastoma cells using calcium release kinetics. Cell Calcium 15: 483-496, 1994.
23. 2+ store depletion? Mol. Pharmacol. 47: 509-516, 1995.
24. Wolsing, D. H., and J. S. Rosenbaum. The mechanism for the rapid desensitization in bradykinin stimulated inositol monophosphate production in NG-108 cells involves interaction of a single receptor with multiple signalling pathways. J. Pharmacol. Exp. Ther. 266: 253-261, 1993.